Aneuro – Advance Neuroscience Research

According to the World Health Organization (WHO), various brain-related diseases including degenerative, functional, and psychiatric disorders, have become a major public health concern. Their impact on social and economic outcomes is even great than cardiovascular diseases and cancers. According to the World Alzheimer Report, in 2015, there were 46,800,000 Alzheimer’s patients worldwide, with an additional 9,900,000 new cases globally. This is equivalent to one new case every three seconds. Case numbers are expected to grow to 74,700,000 by 2030 and 130,000,000 by 2050. The diagnosis and intervention of major brain-related diseases are at the forefront of brain research. This situation actively inspires to promote of the development of the drug industry and new bio-engineering companies. Improving the management of the brain-related disease is thus expected to play an important part in improving the health and well-being of modern society. trem2 protein, Apolipoprotein E protein, Tau protein, Alpha-synuclein Protein, S100B Protein, GFR alpha-like Protein, BACE-1 Protein, Semaphorin 3A Protein, GFAP Protein, TDP-43 Protein, ACHE Protein. As the brand of ACROBiosystems that focused on neuroscience, we aim to promote and facilitate neuroscience research by providing high-quality protein products and valuable new ideas. Our products include target proteins for therapeutic research, biomarker proteins for diagnostic research, pre-formed fibrils (PFFs) for modeling neurodegeneration, and neural factors for cell culture to advance your neuroscience research.